Netherlands Heart Journal

, Volume 20, Issue 6, pp 279–287 | Cite as

Conflict of interest policies and disclosure requirements among European Society of Cardiology national cardiovascular journals

  • F. Alfonso
  • A. Timmis
  • F. J. Pinto
  • G. Ambrosio
  • H. Ector
  • P. Kulakowski
  • P. Vardas
  • on behalf of the Editors’ Network European Society of Cardiology Task Force
Special Article


Disclosure of potential conflicts of interest (COI) is used by biomedical journals to guarantee credibility and transparency of the scientific process. COI disclosure, however, is not systematically nor consistently dealt with by journals. Recent joint editorial efforts paved the way towards the implementation of uniform vehicles for COI disclosure. This paper provides a comprehensive editorial perspective on classical COI-related issues. New insights into current COI policies and practices among European Society of Cardiology national cardiovascular journals, as derived from a cross-sectional survey using a standardised questionnaire, are discussed.


Conflict of interest Disclosure Editorial ethics Journals 


  1. 1.
    International Committee of Medical Journals Editors. Uniform Requirements for Manuscript Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication. (Updated October 2008). Available:
  2. 2.
    Council of Science Editors. CSE’s White Paper on Promoting Integrity in Scientific Journal Publications. Editorial policy committee (2005–2006). Available:
  3. 3.
    World Association of Medical Editors. WAME recommendations on Publication Ethics and Policies for Medical Journals. Available:
  4. 4.
    Committee On Publication Ethics. COPE. Code of Conduct and Best Practice Guidelines for Journal Editors. Available: .
  5. 5.
    Alfonso F, Bermejo J, Segovia J. New recommendations of the international committee of medical journal editors. Shifting focus: from uniformity in technical requirements to bioethical considerations. Rev Esp Cardiol. 2004;57(6):592–3.PubMedCrossRefGoogle Scholar
  6. 6.
    Blum JA, Freeman K, Dart RC, et al. Requirements and definitions in conflict of interest policies of medical journals. JAMA. 2009;302(20):2230–4.PubMedCrossRefGoogle Scholar
  7. 7.
    Cooper RJ, Gupta M, Wilkes MS, et al. Conflict of interest disclosure policies and practices in peer-reviewed biomedical journals. J Gen Intern Med. 2006;21(12):1248–52.PubMedCrossRefGoogle Scholar
  8. 8.
    Bekelman JE, MPhil YL, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA. 2003;289(4):454–65.PubMedCrossRefGoogle Scholar
  9. 9.
    DeAngelis CD, Fontanarosa PB. Resolving unreported conflicts of interest. JAMA. 2009;302(2):198–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Studdert DM, Mello MM, Phil M, et al. Financial conflicts of interest in physicians´ relationships with the pharmaceutical industry. Self-regulation in the shadow of federal prosecution. N Engl J Med. 2004;351:1891–900.PubMedCrossRefGoogle Scholar
  11. 11.
    Drazen JM, Van der Weyden MB, Sahni P, et al. Uniform format for disclosure of competing interests in ICMJE journals. N Engl J Med. 2009;361(19):1896–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Drazen JM, de Leeuw PW, Laine C, et al. Toward more uniform conflict disclosures - The updated ICMJE conflict of interest reporting form. N Engl J Med. 2010;363(2):188–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Alfonso F, Ambrosio G, Pinto FJ, et al. European National Society cardiovascular journals. Background, rationale and mission statement of the “Editors’ Club”. Rev Esp Cardiol. 2008;61(6):644–50.PubMedCrossRefGoogle Scholar
  14. 14.
    Alfonso F, Ambrosio G, Pinto FJ, et al. Editors’ Network ESC Task Force. European Society of Cardiology national cardiovascular journals: the ‘Editors’ Network’. Eur Heart J. 2010;31(1):26–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Mills P, Timmis A, Huber K, et al. The role of European national journals in education. Heart. 2009;95(24):e3.PubMedCrossRefGoogle Scholar
  16. 16.
    Alfonso F. The Editors’ Network of the European Society of Cardiology. Eur Heart J. 2011;32(8):919–21.Google Scholar
  17. 17.
    Schwartz RS, Curfman GD, Morrissey S, et al. Full disclosure and the funding of biomedical research. N Engl J Med. 2008;358(17):1850–1.PubMedCrossRefGoogle Scholar
  18. 18.
    Simone J. More interest in conflicts of interest. Lancet Oncol. 2009;10:836–7.PubMedCrossRefGoogle Scholar
  19. 19.
    Conti RC. Conflict of interest. Clin Cardiol. 2009;32:666–7.CrossRefGoogle Scholar
  20. 20.
    Fontanarosa PB, Flanagin A, DeAngelis CD. Reporting conflicts of interest, financial aspects of research and role of sponsors in funded studies. JAMA. 2005;294(1):110–1.PubMedCrossRefGoogle Scholar
  21. 21.
    Alpert JS. Doctors and the drug industry: how can we handle potential conflicts of interest? Am J Med. 2005;118(2):99–100.PubMedCrossRefGoogle Scholar
  22. 22.
    Alpert JS. Doctors and the drug-industry: further thoughts for dealing with potential conflicts of interest? Am J Med. 2008;121(4):253–5.PubMedCrossRefGoogle Scholar
  23. 23.
    Lanier WL. Bidirectional conflicts of interest involving industry and medical journals: who will champion integrity? Mayo Clin Proc. 2009;84(9):771–5.PubMedCrossRefGoogle Scholar
  24. 24.
    Bove A. Relations with industry: thoughts on claims of a broken system. J Am Coll Cardiol. 2009;54(2):177–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Bodenheimer T. The uneasy alliance: clinical investigators and the pharmaceutical industry. N Engl J Med. 2000;342(20):1539–44.PubMedCrossRefGoogle Scholar
  26. 26.
    Goldacre B. Is the conflict of interest unacceptable when drug companies conduct trials on their own drugs? Yes. BMJ. 2009;339:b4949.PubMedCrossRefGoogle Scholar
  27. 27.
    Davidoff F, de Angelis CD, Drazen JM, et al. International Committee of Medical Journal Editors. Sponsorship, authorship and accountability. Lancet. 2001;358:854–6.PubMedCrossRefGoogle Scholar
  28. 28.
    Johns MM, Barners M, Florencio PS. Restoring balance to industry-academia relationships in an era of institutional financial conflicts of interest: promoting research while maintaining trust. JAMA. 2003;289(6):741–6.PubMedCrossRefGoogle Scholar
  29. 29.
    Alfonso F, Segovia J, Heras M, et al. Publication of clinical trials in scientific journals: Editorial issues. Rev Esp Cardiol. 2006;59(11):1206–14.PubMedCrossRefGoogle Scholar
  30. 30.
    Patsopoulos NA, Analatos AA, Ioannidis JP. Origin and funding of the most frequently cited papers in medicine: database analysis. BMJ. 2006;332(7549):1061–4.PubMedCrossRefGoogle Scholar
  31. 31.
    Lexchin J, Bero LA, Djulbegovic B, et al. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ. 2003;326(7400):1167–70.PubMedCrossRefGoogle Scholar
  32. 32.
    Finucane TE, Boult CE. Association of funding and findings of pharmaceutical research at a meeting of a medical professional society. Am J Med. 2004;117(11):842–5.PubMedCrossRefGoogle Scholar
  33. 33.
    Hirsch LJ. Conflicts of interest, authorship, and disclosures in industry-related scientific publications: The tort bar and editorial oversight of medical journals. Mayo Clin Proc. 2009;84(9):811–21.PubMedCrossRefGoogle Scholar
  34. 34.
    Krzyanowska MK, Pintilie M, Tannock IF. Factors associated with failure to publish large randomized trials presented at an oncology meeting. JAMA. 2003;290(4):495–501.CrossRefGoogle Scholar
  35. 35.
    Chan AW, Krleza-Jerić K, Schmid I, et al. Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ. 2004;171(7):735–40.PubMedCrossRefGoogle Scholar
  36. 36.
    Alfonso F, Bermejo J, Segovia J. Duplicate or redundant publication: can we afford it? Rev Esp Cardiol. 2005;58(5):601–4.PubMedCrossRefGoogle Scholar
  37. 37.
    Hirsch L. Randomized clinical trials: what gets published, and when? CMAJ. 2004;170(4):481–3.PubMedGoogle Scholar
  38. 38.
    Kjaergard LL, Als-Nielsen B. Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ. BMJ. 2002;325(7358):249.PubMedCrossRefGoogle Scholar
  39. 39.
    Ridker PM, Torres J. Reported outcomes in major cardiovascular clinical trials funded by for profit and not-for-profit organizations: 2000–2005. JAMA. 2006;295(19):2270–4.PubMedCrossRefGoogle Scholar
  40. 40.
    Krimsky S, Rothenberg LS. Conflict of interest policies in science and medical journals: editors practices and authors disclosures. Sci Eng Ethics. 2001;7(2):205–18.PubMedCrossRefGoogle Scholar
  41. 41.
    Ancker JS, Flanagin A. A comparison of conflict of interest policies at peer-reviewed journals in different scientific disciplines. Sci Eng Ethics. 2007;13(2):147–57.PubMedCrossRefGoogle Scholar
  42. 42.
    Weinfurt KP, Seils DM, Tzeng JP, et al. Consistency of financial interest disclosures in the biomedical literature: The case of coronary stents. PLoS ONE. 2008;3(5):e2128.PubMedCrossRefGoogle Scholar
  43. 43.
    Smith R. Medical journals are an extension of the marketing arm of pharmaceutical companies. PLoS Med. 2005;2(5):e138.PubMedCrossRefGoogle Scholar
  44. 44.
    Editors T. Publishing commentary by authors with potential conflicts of interest: When, Why and How. Annals Intern Med. 2004;141(1):73–4.Google Scholar
  45. 45.
    Vorobiof G. Do conflict of interest really matter or does no one read the fine print anyway? J Am Coll Cardiol. 2008;51(19):1911.PubMedCrossRefGoogle Scholar
  46. 46.
    Tanne JH. US Senate committee investigates conflicts of interest in industry funded medical education. BMJ. 2009;339:b3139.PubMedCrossRefGoogle Scholar
  47. 47.
    Rothman KJ. Conflict of interest. The new McCarthyism in science. JAMA. 1993;269(21):2782–4.PubMedCrossRefGoogle Scholar
  48. 48.
    Avanzas P, Bayes-Genis A, Pérez de Isla L, et al. Ethical considerations in the publication of scientific articles. Rev Esp Cardiol. 2011;64(5):427–9.PubMedCrossRefGoogle Scholar
  49. 49.
    Relations between professional medical associations and the health-care industry, concerning scientific communication and continuing medical education: a Policy Statement from the European Society of Cardiology Eur Heart J. 2012 March; 33(5): 666–674Google Scholar

Copyright information

© Springer Media / Bohn Stafleu van Loghum 2012

Authors and Affiliations

  • F. Alfonso
    • 1
  • A. Timmis
    • 2
  • F. J. Pinto
    • 3
  • G. Ambrosio
    • 4
  • H. Ector
    • 5
  • P. Kulakowski
    • 6
  • P. Vardas
    • 7
  • on behalf of the Editors’ Network European Society of Cardiology Task Force
  1. 1.Clinico San CarlosMadridSpain
  2. 2.Department of CardiologyLondon Chest HospitalLondonUK
  3. 3.Department of CardiologyLisbon University Medical SchoolLisbonPortugal
  4. 4.University of Perugia School of MedicinePerugiaItaly
  5. 5.Acta CardiologicaLeuvenBelgium
  6. 6.Kardiologia PolskaWarsawPoland
  7. 7.Cardiology DepartmentHeraklion University HospitalHeraklionGreece

Personalised recommendations